Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival.

Prativa SahooPaul FrankelJulie ResslerMargarita GutovaAlexander J AnnalaBenham BadieJana PortnowKaren S AboodyMassimo D'Apuzzo Russell C Rockne

Published in: Stem cells international (2018)

The change in perfusion parameter values from 1 week to 1 month following NSC-mediated therapy combined with contrast-enhancing volume may be a useful biomarker to predict overall survival in patients with recurrent high-grade glioma.

Keyphrases

high grade
contrast enhanced
low grade
stem cells
magnetic resonance imaging
magnetic resonance
computed tomography
diffusion weighted imaging
free survival
randomized controlled trial
bone marrow
network analysis